At the forefront of early-stage RNAi and IFN decoy therapeutics research, our team leverages cutting-edge technologies to unlock the potential of these innovative approaches, aiming to develop treatments for critical unmet medical needs.
RNAi Therapeutics - Psoriasis
Interferon Decoys - Anti-IFN Autoantibodies
ADAM10 mAB
